Page last updated: 2024-11-07

protoporphyrinogen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Protoporphyrinogen is a precursor to heme, a molecule essential for oxygen transport in red blood cells. It is synthesized through a series of enzymatic reactions in the mitochondria, starting with the condensation of succinyl CoA and glycine. Protoporphyrinogen is studied extensively because defects in its biosynthesis can lead to various porphyrias, a group of genetic disorders characterized by the accumulation of porphyrin precursors in the body. These disorders can cause a range of symptoms including skin sensitivity to sunlight, neurological problems, and abdominal pain.'

Cross-References

ID SourceID
PubMed CID121893
CHEBI ID15435
SCHEMBL ID52258
MeSH IDM0057899

Synonyms (22)

Synonym
CHEBI:15435
7,12-diethenyl-3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,18-dipropanoic acid
protoporphyrin ix, 5,10,15,20,22,24-hexahydro deriv. (6ci)
protoporphyrinogen ix (7ci,8ci)
21h,23h-porphine-2,18-dipropanoic acid, 7,12-diethenyl-5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-
protoporphyrin ix, 5,10,15,20,22,24-hexahydro deriv.
21h,23h-porphine-2,18-dipropanoic acid, 7,12-diethenyl-5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl- (9ci)
PROTOPORPHYRINOGEN ,
C01079
7412-77-3
protoporphyrinogen ix
3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid
SCHEMBL52258
DTXSID90225068
3-[20-(2-carboxyethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid
7,12-diethenyl-3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,18-dipropanoate
7,12-diethenyl-5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoic acid
5,10,15,20,22,24-hexahydro protoporphyrin ix deriv.
protoporphyrinogen-ix
7,12-diethenyl-5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoate
UHSGPDMIQQYNAX-UHFFFAOYSA-N
Q27089437

Research Excerpts

Overview

Protoporphyrinogen oxidase (PPO) is a flavin adenine dinucleotide (FAD)-containing enzyme in the tetrapyrrole biosynthetic pathway. It leads to the formation of both heme and chlorophylls, which has been identified as one of the most important action targets of commercial herbicides.

ExcerptReferenceRelevance
"Protoporphyrinogen oxidase (PPO) is a flavin adenine dinucleotide (FAD)-containing enzyme in the tetrapyrrole biosynthetic pathway that leads to the formation of both heme and chlorophylls, which has been identified as one of the most important action targets of commercial herbicides. "( A capillary electrophoresis assay for recombinant Bacillus subtilis protoporphyrinogen oxidase.
Jiang, DQ; Li, HY; Sun, L; Tan, Y; Xi, Z; Yan, XP; Yang, GF; Yang, X, 2008
)
2.02
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
porphyrinogensHexahydroporphyrins in which the nitrogen atoms and four meso positions are saturated.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (13)

PathwayProteinsCompounds
Metabolism14961108
Porphyrin metabolism2344
Heme biosynthesis1530
Porphyrin Metabolism1636
Acute Intermittent Porphyria1636
Porphyria Variegata (PV)1636
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease1636
Hereditary Coproporphyria (HCP)1636
Porphyrin_metabolism ( Porphyrin metabolism )716
HMOX1 pathway (COVID-19 Disease Map)3630
Hemesynthesis defects and porphyrias018
heme biosynthesis from uroporphyrinogen-III II012
Biochemical pathways: part I0466
Heme synthesis324

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (26.92)18.7374
1990's14 (26.92)18.2507
2000's9 (17.31)29.6817
2010's11 (21.15)24.3611
2020's4 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.74 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index54.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.89%)5.53%
Reviews2 (3.77%)6.00%
Case Studies1 (1.89%)4.05%
Observational0 (0.00%)0.25%
Other49 (92.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]